CASP5
Basic information
Region (hg38): 11:104994235-105023168
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CASP5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 36 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 4 | 0 |
Variants in CASP5
This is a list of pathogenic ClinVar variants found in the CASP5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-104995788-G-A | Uncertain significance (Mar 07, 2024) | |||
11-104995793-A-G | not specified | Uncertain significance (Nov 25, 2024) | ||
11-104995826-T-C | not specified | Uncertain significance (Mar 18, 2024) | ||
11-104997406-G-A | not specified | Uncertain significance (Oct 07, 2024) | ||
11-104997445-C-G | not specified | Likely benign (Mar 16, 2022) | ||
11-104997471-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
11-104998899-C-G | not specified | Uncertain significance (Jan 18, 2023) | ||
11-104998905-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
11-105000275-T-C | not specified | Uncertain significance (Feb 10, 2022) | ||
11-105000288-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
11-105000299-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
11-105000309-T-G | not specified | Uncertain significance (Nov 14, 2024) | ||
11-105000390-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
11-105000401-T-C | not specified | Uncertain significance (May 07, 2024) | ||
11-105000443-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
11-105002065-C-T | not specified | Uncertain significance (Nov 15, 2024) | ||
11-105002078-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
11-105002082-C-G | not specified | Uncertain significance (Sep 23, 2023) | ||
11-105002134-T-A | not specified | Uncertain significance (Jun 28, 2022) | ||
11-105002146-T-A | not specified | Uncertain significance (Oct 22, 2021) | ||
11-105002162-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
11-105002168-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
11-105002173-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
11-105002174-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
11-105003320-C-A | not specified | Uncertain significance (Apr 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CASP5 | protein_coding | protein_coding | ENST00000393141 | 9 | 28934 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.75e-16 | 0.00362 | 125270 | 2 | 474 | 125746 | 0.00189 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.468 | 231 | 252 | 0.917 | 0.0000136 | 2960 |
Missense in Polyphen | 58 | 67.072 | 0.86475 | 844 | ||
Synonymous | -1.60 | 112 | 92.5 | 1.21 | 0.00000538 | 829 |
Loss of Function | -0.407 | 23 | 21.0 | 1.10 | 0.00000117 | 257 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00456 | 0.00455 |
Ashkenazi Jewish | 0.000894 | 0.000893 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.00266 | 0.00264 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000825 | 0.000817 |
Other | 0.00296 | 0.00294 |
dbNSFP
Source:
- Function
- FUNCTION: Mediator of programmed cell death (apoptosis). During non-canonical inflammasome activation, cuts CGAS and may play a role in the regulation of antiviral innate immune activation (PubMed:28314590). {ECO:0000269|PubMed:28314590}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Nucleotide-binding Oligomerization Domain (NOD) pathway;Vitamin D Receptor Pathway;internal ribosome entry pathway;DroToll-like
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.996
- rvis_EVS
- 1.2
- rvis_percentile_EVS
- 92.98
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- N
- hipred_score
- 0.133
- ghis
- 0.387
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.235
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- proteolysis;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;substantia nigra development;cellular response to mechanical stimulus;apoptotic signaling pathway;execution phase of apoptosis
- Cellular component
- cytoplasm;NLRP1 inflammasome complex
- Molecular function
- cysteine-type endopeptidase activity;cysteine-type peptidase activity;cysteine-type endopeptidase activity involved in apoptotic process;cysteine-type endopeptidase activity involved in apoptotic signaling pathway